EPS15–NTRK1: a novel NTRK1 oncogenic fusion in patient with lung adenocarcinoma
Sign Up to like & getrecommendations! Published in 2020 at "Journal of Cancer Research and Clinical Oncology"
DOI: 10.1007/s00432-020-03416-2
Abstract: Depending on the clinical scenarios, merely 0.1–3.3% NTRK fusions are demonstrated in lung cancer, but the remarkable efficacy of Trk inhibitors offers a possibility to use NTRK fusion as antitumorigenic target (Harada et al. 2020).… read more here.
Keywords: ntrk fusion; eps15 ntrk1; lung; fusion ... See more keywords